Session » Rheumatoid Arthritis: Human Etiology and Pathogenesis II

Meeting: 2013 ACR/ARHP Annual Meeting

Abstract Number: 2393

Involvement Of Transitional T Follicular Like Helper Cells Bearing Triple Phenotypes Of Tfh/Th1/Th17 In The Pathogenesis Of Rheumatoid Arthritis

Abstract Number: 2394

In Rheumatoid Arthritis, Smoking Is Not Primarily Associated With Anti-Citrullinated Protein Antibodies, But With The Presence Of Multiple Autoantibodies

Abstract Number: 2395

Plasma Short-Talin Is a New Rheumatoid Arthritis Monitoring Biomarker Independent Of The Inflammatory Markers

Abstract Number: 2396

PI3Kdelta Regulates Invadosome Formation and Invasiveness Of Fibroblast-Like Synoviocyte In Rheumatoid Arthritis

Abstract Number: 2397

To Which Extent May The Familial Risk Of Rheumatoid Arthritis Be Explained By Established Risk Factors?

Abstract Number: 2398

Redox Mediated Angiogenesis In The Hypoxic Joint Of Inflammatory Arthritis

Abstract Number: 2399

Altered Histone Methylation Is Associated With IL-6 Dependent Matrix Metalloproteinases Gene Transcriptional Activation In Rheumatoid Arthritis Synovial Fibroblasts

Abstract Number: 2400

Targeted Exon Resequencing For Korean Rheumatoid Arthritis

Abstract Number: 2401

Disease Activity (DAS-28CRP) In Rheumatoid Arthritis Correlates With Synovial Expression Of Tumor-Associated and IL-6-Dependent Genes

Abstract Number: 2402

Association Between Life Events and Rheumatoid Arthritis, Results From The EIRA Case Control Study

Abstract Number: 2403

The Incidence Of Factor V Leiden A1691G, Methylene Tetrahydrofolate Reductase C677T, and Prothrombin G20210A Mutation In Patients With Rheumatoid Arthritis

Abstract Number: 2404

CXCL13-Producing CD4 T-Cells In Rheumatoid Synovitis Are a Distinct Subset

Abstract Number: 2405

Respiratory Diseases As Risk Factors For Rheumatoid Arthritis

Abstract Number: 2406

The Relationship Between Anti-Citrullinated Protein Antibodies and Radiographic Damage In African-Americans With Rheumatoid Arthritis

Abstract Number: 2407

Rheumatoid Arthritis-Related Autoantibodies In The Lung Evolve Over Time In Subjects At Elevated Risk For Future Rheumatoid Arthritis

Abstract Number: 2408

Secretory Leukocyte Protease Inhibitor Released By Rheumatoid Synovial Fibroblasts Exerts a Negative Control Of BAFF-Dependent B Cell Activation In Vitro and In Vivo In The Collagen-Induced and Chimeric RA/SCID Arthritis Models

Abstract Number: 2409

Association Of High Serum Interleukin-23 Levels With Porphyromonas Gingivalis Antibodies In Patients With Early Rheumatoid Arthritis

Abstract Number: 2410

Effects Of Leptin and Adiponectin On Proliferation and Activation Were Are Significantly Increased In CD4⁺ T Cells From Rheumatoid Arthritis Patients

Abstract Number: 2411

The Peripheral Blood T Cell Repertoire Before The Clinical Onset Of Rheumatoid Arthritis – a Study Of Incident Cases and Controls

Abstract Number: 2412

Anti-CCP Antibodies and Increased Cartilage Turnover In Patients Developing Rheumatoid Arthritis

Abstract Number: 2413

Expression and Function Of a YAP, a Novel Pathway In Fibroblast-Like Synoviocyte In Rheumatoid Arthritis

Abstract Number: 2414

Elevated Serum Resistin Levels In Rheumatoid Arthritis With Periodontitis

Abstract Number: 2415

Phosphorylated Venous Endothelial Nitric Oxide Synthase Is Elevated In Rheumatoid Arthritis Subjects With High Disease Activity

Abstract Number: 2416

Discovery Of Novel Biomarkers In Rheumatoid Urine : Significance Of Urinary CD14

Abstract Number: 2417

Antibodies To Porphyromonas Gingivalis Peptidylarginine Deiminase In Rheumatoid Arthritis Are Not Directed Against The Autocitrullinated Enzyme

Abstract Number: 2418

The Transmembrane Protein Tyrosine Phosphatase Kappa Promotes Aggressiveness Of Rheumatoid Arthritis Fibroblast-Like Synoviocytes

Abstract Number: 2419

CDK6 Transcripts Expression Control By The Synoviocyte Proliferation Gene, SPACIA1

Abstract Number: 2420

Pleiotropic Roles Of Fcγ Receptors Upregulated On Circulating Monocytes In Rheumatoid Arthritis Patients

Abstract Number: 2421

Association Between Physical Work Load and Rheumatoid Arthritis, Results From The EIRA Case Control Study

Abstract Number: 2422

Anti-P. Gingivalis antibody Is Correlated With Severity Of Periodontitis But Not With Rheumatoid Arthritis Disease Activity In RA

Abstract Number: 2423

Mir-27b As Biomarker and Regulator Of IL-6R Pathway In Resistant Rheumatoid Arthritis Monocyte

Abstract Number: 2424

Investigation Of The Role Of Histone Deacetylases In Rheumatoid Arthritis Synovial Fibroblasts

Abstract Number: 2425

Impaired TNFá Production By Dendritic Cells From Rheumatoid Arthritis Patients Upon Contact With Porphyromonas Gingivalis

Abstract Number: 2426

Signaling Abnormalities In Neutrophil Granulocytes Of Rheumatoid Arthritis Patients Are Associated With Increased Extracellular Trap Formation and Provide a Basis For The Induction Of Anti-Citrullinated Peptide Antibodies

Abstract Number: 2427

Enhanced Expression Of mRNA For Triggering Receptor Expressed On Myeloid Cells 1 In CD34+ Cells Of The Bone Marrow In Rheumatoid Arthritis

Abstract Number: 2428

Suppression Of Tumor Necrosis Factor Receptor Associated Factor (TRAF) 6 Attenuates The Proinflammatory Effect Of Rheumatoid Arthritis Fibroblast-Like Synoviocytes

Abstract Number: 2429

Enhanced Responsiveness To Stimulation and Increased Extrusion Of Extracellular Traps By Rheumatoid Arthritis Neutrophil Granulocytes and of Healthy Control Neutrophils to Serum and Synovial Fluid From Rheumatoid Arthritis Patients

Abstract Number: 2430

Antibodies To Porphyromonas Gingivalis as An Etiological Clue To The Development Of Anti-Citrullinated Protein Antibody Positive Rheumatoid Arthritis

Abstract Number: 2431

Association Of T Follicular Helper / Th17 T Cell and Memory B Cell Populations In Rheumatoid Arthritis With Disease Activity and Therapy With TNF Antagonists

Abstract Number: 2432

Characterization Of Lung Inflammation and Identification Of Shared Citrullinated Targets In The Lungs and Joints Of Early RA

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under embargo once the ACR has notified presenters of their abstract’s acceptance, and cannot be presented at other meetings after this time. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until November 7 at 10:00 AM ET. Journalists with access to embargoed information also cannot release articles before this time.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Permissions and Reprints

For information about abstract permissions and reprints, see ACR Convergence permissions and reprint policies.